Literature DB >> 25835740

Induction of experimental obstructive cholestasis in mice.

C G Tag1, S Weiskirchen1, K Hittatiya2, F Tacke3, R H Tolba4, R Weiskirchen5.   

Abstract

The induction of experimental obstructive cholestasis is a reliable model for cholestatic liver diseases in rodents. Bile duct ligation (BDL) in mice provokes typical time-dependent morphological and structural changes in the liver, ranging from liver cell injury and elevated serum enzyme levels after several days, to a severe inflammatory response in the liver after 5-7 days, up to an advanced hepatic fibrosis as soon as three to four weeks after surgical ligation of the common biliary duct. Upon BDL induction, hepatic stellate cells become activated and transdifferentiate into myofibroblasts that produce extracellular matrix proteins such as collagen. In principle, the periportal fibrosis induced by BDL in rat livers is reversible. After the relief of a biliary obstruction, the liver has the capacity to revert to a nearly normal histological architecture and a fully normal biochemical function. When BDL surgery is performed by an experienced scientist, this model has very high reproducibility among all fibrotic models. All these factors corroborate the outstanding value of this model for basic and translational research in biomedicine and hepatology. Nevertheless, this model can result in significant variations when surgery is carried out by untrained personnel or when unconscious modifications are implemented that affect the quality of the intervention. A detailed protocol is provided here for the provision of reliable and reproducible BDL in mice.
© The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  biliary obstruction; cell infiltration; cirrhosis; fibrosis; jaundice

Mesh:

Year:  2015        PMID: 25835740     DOI: 10.1177/0023677214567748

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  18 in total

1.  Dexmedetomidine activates the PI3K/Akt pathway to inhibit hepatocyte apoptosis in rats with obstructive jaundice.

Authors:  Yaying Xie; Chunyan Guo; Ye Liu; Luanyuan Shi; Jianshe Yu
Journal:  Exp Ther Med       Date:  2019-10-08       Impact factor: 2.447

2.  Murine model of long-term obstructive jaundice.

Authors:  Hiroaki Aoki; Masayo Aoki; Jing Yang; Eriko Katsuta; Partha Mukhopadhyay; Rajesh Ramanathan; Ingrid A Woelfel; Xuan Wang; Sarah Spiegel; Huiping Zhou; Kazuaki Takabe
Journal:  J Surg Res       Date:  2016-07-18       Impact factor: 2.192

3.  A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation.

Authors:  Roosmarijn E Vandenbroucke; Christophe Van Steenkiste; Wouter Claeys; Lien Van Hoecke; Anja Geerts; Hans Van Vlierberghe; Sander Lefere; Griet Van Imschoot; Elien Van Wonterghem; Bart Ghesquière
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

4.  Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin.

Authors:  Mari Saif; Wilhelmus J Kwanten; Jessica A Carr; Ivy X Chen; Jessica M Posada; Amitabh Srivastava; Juanye Zhang; Yi Zheng; Matthias Pinter; Sampurna Chatterjee; Samir Softic; C Ronald Kahn; Klaus van Leyen; Oliver T Bruns; Rakesh K Jain; Moungi G Bawendi
Journal:  Nat Biomed Eng       Date:  2020-06-22       Impact factor: 25.671

5.  A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury.

Authors:  Sarah A Taylor; Xin-Yi Yeap; Jiao-Jing Wang; Kyle D Gromer; Alyssa Kriegermeier; Richard M Green; Zheng J Zhang
Journal:  Physiol Rep       Date:  2020-05

6.  Hepatoprotective effect of ultrasonicated ginseng berry extract on a rat mild bile duct ligation model.

Authors:  Yoonjin Nam; Sung Kwon Ko; Uy Dong Sohn
Journal:  J Ginseng Res       Date:  2018-08-10       Impact factor: 6.060

7.  Spontaneous remission of obstructive jaundice in rats: Selection of experimental models.

Authors:  Yunfu Lv; Jie Yue; Xiaoguang Gong; Xiaoyu Han; Hongfei Wu; Jie Deng; Yejuan Li
Journal:  Exp Ther Med       Date:  2018-05-02       Impact factor: 2.447

8.  N-Glycosylation of Lipocalin 2 Is Not Required for Secretion or Exosome Targeting.

Authors:  Erawan Borkham-Kamphorst; Eddy Van de Leur; Steffen K Meurer; Eva M Buhl; Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2018-04-25       Impact factor: 5.810

9.  Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver.

Authors:  Gayane Hrachia Buniatian; Ralf Weiskirchen; Thomas S Weiss; Ute Schwinghammer; Martin Fritz; Torgom Seferyan; Barbara Proksch; Michael Glaser; Ali Lourhmati; Marine Buadze; Erawan Borkham-Kamphorst; Frank Gaunitz; Christoph H Gleiter; Thomas Lang; Elke Schaeffeler; Roman Tremmel; Holger Cynis; William H Frey; Rolf Gebhardt; Scott L Friedman; Wolfgang Mikulits; Matthias Schwab; Lusine Danielyan
Journal:  Cells       Date:  2020-02-17       Impact factor: 6.600

10.  Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis.

Authors:  Sha Li; Chenghai Wang; Xiaxia Zhang; Wen Su
Journal:  Front Physiol       Date:  2021-05-31       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.